- Jul 2018
-
europepmc.org europepmc.org
-
On 2015 Jul 27, Chuan-Wei Jang commented:
In the paper, we failed to specify the sources of some antibodies used in the additional experiments a reviewer requested after our initial submission. These antibodies are:
H3K4me2: Active Motif, 39141
CenpA: Abcam, ab33565
TRF1: Alpha Diagnostic International, TRF12-A
TRF2: Novus, NB110
Beta-Actin: Abcam, ab8826
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY. -
On 2015 Jul 16, Chuan-Wei Jang commented:
The figures in the paper have been reduced in size and resolution in the print publication process, and thus some details are compromised in their final form. The original high resolution figures can be viewed or downloaded from here.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-
- Feb 2018
-
europepmc.org europepmc.org
-
On 2015 Jul 16, Chuan-Wei Jang commented:
The figures in the paper have been reduced in size and resolution in the print publication process, and thus some details are compromised in their final form. The original high resolution figures can be viewed or downloaded from here.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY. -
On 2015 Jul 27, Chuan-Wei Jang commented:
In the paper, we failed to specify the sources of some antibodies used in the additional experiments a reviewer requested after our initial submission. These antibodies are:
H3K4me2: Active Motif, 39141
CenpA: Abcam, ab33565
TRF1: Alpha Diagnostic International, TRF12-A
TRF2: Novus, NB110
Beta-Actin: Abcam, ab8826
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-